Enabling Safer Gene Editing
Helex has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Helex's investors include SOSV, Pi Ventures, IndieBio, Bluehill Capital.
Helex is headquartered in New York, United States.
Enabling Safer Gene Editing
Helex is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helex — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/helex. Accessed July 19, 2026.
VCBacked. (2025). Helex — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/helex
{{cite web |title=Helex — Funding & Investors |url=https://www.vcbacked.co/company/helex |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated